Notice of Proposed Sale · 144

Immunome, Inc.

IMNMNASDAQEQUITYCurrent

Notice of Proposed Sale

Filed Jul 6, 2026Accepted Jul 6, 2026, 5:37 PM EDTFiling CIK 1472012Accession 0001628280-26-047387

View company →Permanent SEC source ↗

Structured filing — 144

primary_doc.xml

Open full document ↗

Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.

Proposed-sale notice

Issuer: Immunome, Inc.
Issuer CIK: 0001472012
SEC file number: 001-39580
Phone: 4259397410
Person for whose account securities are to be sold: ABHMC II, LLC
Relationships to issuer: Shareholder
Street: 18702 N. CREEK PARKWAY
Street (continued): SUITE 100
City: BOTHEL
State / country code: WA
Postal code: 98011

Securities proposed for sale

Securities proposed for sale · 1 reported row
Security	Proposed units	Aggregate market value	Units outstanding	Approximate sale date	Exchange	Broker / market maker
Common	100,000	2,361,000	113,250,394	07/06/2026	Nasdaq	Merrill Lynch

Broker / market maker — proposed row 1, entry 1

Name: Merrill Lynch
Street: 555 California Street
Street (continued): 18th Floor
City: San Francisco
State / country code: CA
Postal code: 94104

Acquisition of securities to be sold

Acquisition of securities to be sold · 1 reported row
Security	Acquired	Nature of acquisition	Acquired from	Amount acquired	Gift transaction	Payment date	Nature of payment
Common	10/03/2023	Private Placement	Issuer	100,000	N	10/03/2023	Cash

Sales reported in the preceding three months

Sales reported in the preceding three months · 3 reported rows
Seller	Security	Sale date	Amount sold	Gross proceeds
ABHMC II LLC	Common	06/30/2026	100,000	2,112,450
ABHMC II LLC	Common	07/02/2026	100,000	2,258,949
ARSENAL BRIDGE VENTURE II-B LLC	Common	06/30/2026	1,050	22,180.72

Seller — prior-sale row 1, entry 1

Name: ABHMC II LLC
Street: 4305 AVENUE D
City: AUSTIN
State / country code: TX
Postal code: 78751

Seller — prior-sale row 2, entry 1

Name: ABHMC II LLC
Street: 4305 AVENUE D
City: AUSTIN
State / country code: TX
Postal code: 78751

Seller — prior-sale row 3, entry 1

Name: ARSENAL BRIDGE VENTURE II-B LLC
Street: 4305 AVENUE D
City: AUSTIN
State / country code: TX
Postal code: 78751

Prior-sale reporting

Nothing to report for the preceding three months: N

Notice signature

Notice date: 07/06/2026
Signed: James B. Graham
Plan adoption dates: 03/31/2026

Company context

Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies. We are advancing an innovative portfolio of therapeutics, supported by a leadership team with deep experience in the design, development, and commercialization of cutting-edge therapies, including antibody-drug conjugates. Our pipeline includes varegacestat, an investigational gamma secretase inhibitor for which an NDA has been accepted by the U.S. FDA; IM-1021, a clinical-stage ROR1 ADC; IM-1617, a clinical-stage solid tumor ADC; and IM-3050, a clinical-stage FAP-targeted radioligand therapy. We are also advancing a broad portfolio of early-stage ADCs pursuing undisclosed solid tumor targets.

Current securities

IMNMNASDAQ · EQUITY · Current

Get the free weekly BCS email.